title: Interleukin-10 administration and bacterial endotoxin-induced preterm birth in a rat model.
abstract: OBJECTIVE
  To determine whether intra-uterine infusion of interleukin-10 prevents preterm delivery in rats treated with endotoxin.
  
  
  METHODS
  Pregnant rats underwent implantation of uterine catheters and were randomly assigned to receive intrauterine infusion of either normal saline, 50 microg lipopolysaccharide endotoxin, or 50 microg lipopolysaccharide with 500 ng interleukin-10 administered either concurrently or 24 hours later. The interval from infusion to delivery for each group was recorded, along with the number of live born pups and their birth weight. We calculated that to obtain a power of 80%, assuming a 24-hour difference in the treatment to delivery times between the test and control subjects, at least six animals would be needed in each group.
  
  
  RESULTS
  In females receiving lipopolysaccharide (50 microg) alone, the interval to delivery (P <.05), live birth rate (P <.05), and pup weight (P <.001) were reduced compared with the saline-infused controls. In contrast, females receiving interleukin-10 at the time of the endotoxin challenge or 24 hours after delivered at term with no difference in litter size or live birth weight compared with the controls.
  
  
  CONCLUSIONS
  Animals treated with both lipopolysaccharide and interleukin-10, administered concurrently or 24 hours after the endotoxin challenge, delivered normal weight pups at term with a similar litter size as the saline-infused controls. Interleukin-10 appears to be effective in preventing endotoxin-induced preterm birth and fetal wastage in pregnant rats.
authors.affiliation: Department of Obstetrics and Gynecology, Saint Barnabas Medical Center, Livingston, New Jersey 07039, USA. terrone@excite.com
authors.forename: D A
authors.initials: DA
authors.lastname: Terrone
authors.forename: B K
authors.initials: BK
authors.lastname: Rinehart
authors.forename: J P
authors.initials: JP
authors.lastname: Granger
authors.forename: P S
authors.initials: PS
authors.lastname: Barrilleaux
authors.forename: J N
authors.initials: JN
authors.lastname: Martin
authors.forename: W A
authors.initials: WA
authors.lastname: Bennett
mesh_terms: D000818:Animals; D004195:Disease Models, Animal; D004926:Escherichia coli; D005260:Female; D016753:Interleukin-10 / Q000008:administration & dosage / Q000627:therapeutic use*; D008070:Lipopolysaccharides / Q000009:adverse effects; D007752:Obstetric Labor, Premature / Q000382:microbiology / Q000517:prevention & control*; D011247:Pregnancy; D011897:Random Allocation; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D008070:Lipopolysaccharides; D016753:Interleukin-10